#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Obliterative bronchiolitis Waldenstrom's macroglobulinaemia refractory Precursor T-lymphoblastic lymphoma/leukaemia recurrent Cluster headache Pneumonia Acute myeloid leukaemia Gastric cancer Central nervous system lymphoma Canavan disease Pyruvate dehydrogenase complex deficiency Immunodeficiency common variable Fontan procedure Mucopolysaccharidosis I Arrhythmia Neurofibroma More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Basic Information Biotinidase deficiency – Basic Information Phenylketonuria – Basic Information Rosai-Dorfman syndrome – Life with Disease Burkitt’s lymphoma – Life with Disease Marfan’s syndrome – Treatment Mucopolysaccharidosis II – Treatment Epidermolysis bullosa – Basic Information KBG syndrome – Diagnostics Stevens-Johnson syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alxn1850 Olaparib Dexketoprofen Trometamol Donanemab Pp1815 Chlorpromazine Hydrochloride Tioguanine Ponesimod R-Azasetron Besilate Rebisufligene Etisparvovec Terbinafine Cefazolin Dc-806 Tolebrutinib Ds-3939A Vrdn-001 Gskvx000000008866 Tumour Detection Pentixafor Gallium Ga-68 Citalopram More therapies…

    Learn about Your Condition

    Skin ulcer Hairy cell leukaemia recurrent Hodgkin's disease Oesophageal cancer metastatic KBG syndrome Univentricular heart Skin candida Oedema peripheral Plasma cell myeloma Mixed dementia Alpha-1 antitrypsin deficiency Gingival bleeding Hepatic angiosarcoma Acute on chronic liver failure Merycism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Haematological malignancy

  • Study on Enhanced GVH Prevention in Elderly Patients with Blood Cancer Using Rabbit Anti-Human Thymocyte Immunoglobulin During Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Haematological malignancy
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    France

  • Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Emavusertib
    • Ibrutinib
    Czechia France Italy Poland Spain

  • Long-term Follow-up Study for Patients with Solid and Blood Cancers Treated with Brexucabtagene Autoleucel or Axicabtagene Ciloleucel

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    • Axicabtagene Ciloleucel
    Austria Belgium France Germany Italy The Netherlands +1

  • Continued Treatment Study for Patients with Blood Cancers Using Tafasitamab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Tafasitamab
    Hungary Italy Spain

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Haematological malignancy
    • Neoplasm
    Investigated Drugs:
    • Zilovertamab Vedotin
    Belgium Czechia Denmark France Germany Greece +6

  • Study of AZD2962 tablets alone and with other medications in patients with myelodysplastic syndromes and dysplastic chronic myelomonocytic leukemia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Chronic myelomonocytic leukaemia
    • Haematological malignancy
    Spain
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!